Back to top

Analyst Blog

Varian Medical Systems, Inc. (VAR - Analyst Report) received an order for 20 TrueBeam machines from NHS Supply Chain for NHS hospitals across the U.K. The deal shall be facilitated through the capital equipment fund of NHS hospitals, following the government hospital chain’s acknowledgement of the need to modernize its radiotherapy as well as radiosurgery treatments for patients in the U.K.

The new agreement is the continuation of a successful program launched last year, that completed the delivery of ten such TrueBeam systems to radiotherapy departments of oncology centers located in Newcastle, Liverpool, Hull, Sheffield, Guildford, Hereford, Poole, and London.

Varian's TrueBeam system has been integrated with a host of new technical innovations that includes synchronize imaging, patient positioning, motion management and treatment delivery during a radiotherapy or radiosurgery procedure. The new system also features a high dose delivery rate that shortens the treatment time, as compared with the earlier generations of radiotherapy technology.  TrueBeam can be successfully used for the treatment of lung, breast, intracranial, prostate, head and neck, and other types of cancer.

NHS hospitals spread across the U.K., will benefit from this order as it will get a chance to replace and modernize its base of 300 linear accelerators (100 of these are more than ten years old) with a more advanced and accurate treatment system.
The agreement to supply such systems reflects the demand for highly competent cancer treatment technology in NHS hospitals. The collaboration between Varian and the UK government is expected to save up to approximately 10,000 lives per year.

Varian also gets the opportunity to assert its long standing commitment towards bringing in new, effective and cost-efficient medical technology, thus fulfilling the growing needs of the modern healthcare industry.

Currently, VAR carries a Zacks Rank #3 (Hold).Other medical stocks that are worth a look include Echo Therapeutics, Inc. (ECTE - Snapshot Report), Given Imaging Ltd. , and Luminex Corporation (LMNX - Analyst Report), each carrying a Zacks Rank #2 (Buy).

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
UTD THERAPE… UTHR 117.83 +28.51%
TRIQUINT SE… TQNT 20.67 +6.52%
RF MICRO DE… RFMD 12.47 +6.04%
VASCO DATA… VDSI 14.77 +4.68%
BANCO DO BR… BDORY 15.53 +3.95%